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Ultrasonic carotid plaque characteristics1,2 have
revealed that echolucent plaques are more frequent-
ly associated with neurologic events than echogenic
ones.3,4 Recent publications5,6 have suggested that
computer-based assessment of plaque characteristics
may be a more objective, operator-independent
method for the assessment of plaque echodensity
and the identification of high-risk carotid lesions.
The long-term efficacy of lower limb balloon
angioplasty is limited by restenosis at the site of
angioplasty. Angioplasty works by the mechanism of
disruption and compaction of plaque, with a resul-
tant increase in minimal luminal diameter. Our
group has shown that duplex scanning can be effec-
tively used to study the restenotic process after
angioplasty in iliac and femoropopliteal arteries by
means of frequent measurement of plaque thickness,
minimal luminal diameter (MLD), and peak systolic
velocity ratio (PSVR) at the site of angioplasty,7 and
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this methodology has been described. The hypothe-
sis tested by the work presented in this paper was
that echolucent plaques with their higher content of
cholesterol would be more compressible than
echogenic fibrous plaques; therefore, the immediate
and long-term outcome of angioplasty in these
lesions would be different. The aim of this study was
to determine (1) the relationship between ultrason-
ic plaque morphology and immediate outcome after
angioplasty for (a) increase in MLD, (b) fall in
PSVR, and (c) decrease in plaque thickness; and (2)
the relationship between plaque morphology and
long-term outcome for (a) plaque “growth” and (b)
restenosis.
MATERIAL AND METHODS
Thirty-one stenoses in 17 patients (mean age, 63
years; 13 women/4 men) were included in the study.
Informed consent to participate in the study was
obtained from all patients, and the study was
approved by the institutional review board. All
lesions had more than 70% stenosis and were less
than 5 cm long. The lesions were distributed in the
common iliac (6), external iliac (2), profunda (1),
superficial femoral (21), and popliteal (1) arteries. All
scans were performed on the Hewlett-Packard Sonos
2000 color flow duplex scanner (Andover, Mass)
with the same set of controls (transmit power, gain,
pre- and post-processing curves, compress and
regress) for all iliac examinations, and a different
fixed preset was used for all femoropopliteal scans.
All iliac scans were done at a depth of 4 to 8 cm, and
femoropopliteal scans were done at a depth of 4 to 6
cm with a 4.5/3.5 MHz linear array transducer.
Patients undergoing iliac scans fasted overnight to
reduce bowel gas and were examined in the morning.
All arteries were localized initially on transverse imag-
ing and then examined in the longitudinal mode with
the position of the transducer adjusted to obtain the
maximum thickness of the anterior and posterior
components of the plaque at the site of stenosis.
Images obtained in B-mode and color were stored on
a magneto-optical disk for future retrieval and analy-
sis. Also, the site of stenosis in relation to landmarks
was noted to enable easy localization for future
examinations; the common femoral artery bifurca-
tion and adductor tubercle were used for superficial
femoral artery stenoses, and the anterior superior iliac
spine, symphysis pubis, and umbilicus were used for
iliac examinations. The presence of collaterals was
also noted. Changes in plaque thickness in the ante-
rior and posterior components, MLD, and PSVR at
the site of angioplasty were measured by means of
ultrasound, as shown in Fig. 1. For plaque measure-
ment, the thickest portion of the plaque was mea-
sured, from the luminal surface to the adventitia. For
the MLD, the narrowest portion of the lumen was
measured. To avoid the pitfall of under or over mea-
suring, both color and B-mode images were exam-
ined, because color helped to outline echolucent
plaques. All measurements were performed with the
help of on-screen calipers. For the measurement of
PSVR, V2 and V1 were obtained from an average of
5 separate arterial waveforms. The results of interob-
server variability studies for the measurement of
plaque thickness, MLD, and PSVR have been report-
Fig 1. Measurements made for each stenosis: A, thickness of anterior component of plaque
(mm); B, thickness of posterior component of plaque (mm); C, minimal luminal diameter
(MLD; mm); D, V2, velocity at site of stenosis (cm/s); V1, velocity proximal to stenosis
(cm/sec); peak systolic velocity ratio (PSVR) = V2/V1. An increase in the PSVR of more than
2, in the follow-up period after angioplasty signified restenosis.
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ed by our group previously.7 The correlation coeffi-
cient, mean absolute difference, and 95% limits of
agreement were r = 0.90, 0.06 ± 0.26, –0.46 to 0.58
mm for plaque thickness; r = 0.91, –0.03 ± 0.46 mm,
–0.49 to 0.43 mm for MLD; and r = 0.93, 0.04 ±
0.31, –0.27 to 0.35 for PSVR. 
A baseline scan was performed either on the
morning of or 1 day before angioplasty, and follow-up
was done on day 1, weekly for the first eight weeks,
week 12, week 24, and week 52 (1 year). An increase
of more than 2 in the PSVR in the postangioplasty
period was the criterion used to signify restenosis.
Assessment of plaque characteristics. The
assessment of plaque characteristics was performed on
baseline scans of all stenoses that were subjected to
angioplasty with a computer-based program. For the
purpose of computer-based assessment of plaque char-
acter, all digitized images were transferred from the
magneto-optical disc to a Dell PC (120 MHz Pentium
processor, 32 MB RAM; Dell Computer, Bracknell,
UK). By means of a computer program (Adobe
Photoshop, Adobe Systems, Mountain View, Calif), all
B-mode images were normalized using 2 reference
points, blood and adventitia. The darkest part of the
lumen (blood) was assigned a gray level between 0 and
5, and the brightest portion of the adventitia was given
a level between 180 and 190 on a linear scale of 0 to
255 (0 = absolutely dark; 255 = absolutely white).
However, the outline of echolucent plaques may not
be easily defined on B-mode imaging. Therefore, in
instances in which plaques were echolucent, the color
image was used to help the operator define the outline
of the plaque. The plaque on the B-mode black-and-
white image was then outlined with a computer
mouse. The gray-scale median (GSM) of the pixels of
the plaque was obtained and used as a measure of
plaque echodensity. Figs. 2 and 3 illustrate the pixel
histogram. The number of pixels is on the Y-axis, and
the gray scale is on the X-axis. The GSM in Fig. 2 is 6,
indicating an echolucent plaque; in contrast, the GSM
in Fig. 3 is 35, indicating an echogenic plaque. The
spectral broadening reflects the extent of homogeneity
or heterogeneity. When a stenosis had both an anteri-
or and posterior component, an average of the 2 medi-
ans was taken. All stenoses undergoing angioplasty had
the GSM of plaques assessed before the procedure.
Fig 2. Gray-scale median (GSM) of a stenosis in the superficial femoral artery. The plaque was
echolucent and had a GSM of 6.
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Reproducibility of plaque gray-scale median.
The reproducibility of GSM measurements was
assessed by conducting an interobserver study
between 2 of the authors (G.R. and T.T.); each
observer independently standardized the images
from the magneto-optical disc and obtained the
mean gray scale of the plaque. The GSM of plaques
from 30 stenoses were measured, and the results
were compared. The results were analyzed for (1)
between observer variability (coefficient of correla-
tion [r]) and (b) 95% limits of agreement: the mean
± (2 SD) of the absolute difference in measurement
between 2 observers. 
Relationship between plaque gray-scale medi-
an and outcome after angioplasty. The relation-
ship between plaque GSM and immediate outcome
after angioplasty with regard to the total plaque
thickness, minimal luminal diameter, and peak sys-
tolic velocity ratio was determined (Fig. 1). Also, the
relationship between plaque GSM and restenosis for
increase in PSVR of more than 2.0 and the absolute
plaque “growth” in the postangioplasty period were
studied. The following equations were used to cal-
culate the reduction in plaque thickness immediate-
ly after angioplasty, increase in MLD, percent
decrease in PSVR, and absolute plaque “growth”
after angioplasty. 
Reduction in plaque thickness immediately after
angioplasty
Total plaque thickness preangioplasty (mm) = 
sum of anterior + posterior plaque (A)
Total plaque thickness on day 1 postangioplasty
(mm) = sum of anterior + posterior plaque (B)
Absolute reduction in plaque thickness = 
A – B (mm)……….(1).
Increase in minimal luminal diameter (MLD)
after angioplasty 
MLD (mm) preangioplasty = C
MLD (mm) postangioplasty = D
Absolute increase in MLD after angioplasty = 
D – C (mm)……….(2)
Fig 3. Gray-scale median (GSM) of a stenosis in the superficial femoral artery. The plaque was
echogenic and had a GSM of 35.
Reduction in peak systolic velocity ratio (PSVR)
after angioplasty
PSVR (preangioplasty) = E
PSVR (postangioplasty) = F
% decrease in PSVR = 100 – ([F/E] ·
100)……….(3)
Absolute plaque “growth” after angioplasty
Plaque thickness on day 1 (mm) = B
Plaque thickness at final visit or at time of
restenosis (mm) = G
Absolute plaque “growth” (mm) = 
G – B……….(4)
RESULTS
The results of the interobserver variability for the
measurement of plaque GSM of 30 stenoses showed
a coefficient of correlation (r) of 0.93, and the 95%
limit of agreement was –4.1 to 5.9.
Relationship between plaque GSM and imme-
diate outcome after angioplasty. Fig. 4 is an exam-
ple of an echolucent plaque in the superficial femoral
artery with a GSM of 6. The anterior plaque was 4.31
mm, the MLD 1.14 mm, and the PSVR 2.85. Fig. 5
shows the same plaque on day 1 after angioplasty; the
anterior plaque reduced in thickness to 1.32 mm (the
absolute reduction in plaque thickness was 2.99 mm),
the MLD increased to 5.02 mm (the absolute increase
was 3.88 mm), and the PSVR decreased to 1.03 (the
percent decrease was 64%). Angioplasty achieved its
effect by means of compression of the echolucent
plaque. Fig. 6 is an example of a fibrous plaque in the
superficial femoral artery with a GSM of 35. The pos-
terior plaque measured 3.96 mm, the MLD 2.11 mm,
and the PSVR 2.46. Fig. 7 shows the same plaque on
day 1 after angioplasty; the posterior plaque thickness
was reduced to 3.91 mm (the absolute decrease in
plaque thickness was 0.05 mm), the MLD increased to
3.69 mm (the absolute increase was 1.58 mm), and
the PSVR decreased to 1.77 (the percent decrease was
28%). Angioplasty achieved its effect by means of
dilatation of the arterial wall with minimal plaque
compression. 
The plaque GSM of the 31 stenoses subjected to
angioplasty ranged from 6 to 71 (mean, 31.3 ± 17.9)
(from echolucent to very echogenic [fibrous]
plaques). For the purpose of analysis of the results, an
arbitrary cutoff point of 25 in the GSM was taken to
see if separation of the stenoses for outcome could be
seen. Based on this, 2 groups were available for com-
parison of the results of angioplasty: group A, with a
GSM less than 25, consisting of 17 stenoses (mean,
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18.7 ± 5.3) and group B, with GSM greater than 25,
consisting of 14 stenoses (mean 46.4 ± 15.8).
Table I shows the relationship between GSM and
plaque thickness (mm), before and on day 1 after
angioplasty. When the GSM was less than 25, the
absolute reduction in plaque thickness (mm) on day
1 was significantly greater than when the GSM was
greater than 25 (P < .03). There was no relationship
between GSM and increase in MLD and percentage
decrease in PSVR at the site of angioplasty. 
Relationship between plaque gray-scale medi-
an and restenosis. The relationship between plaque
GSM and restenosis based on the increase in PSVR of
more than 2.0 is shown in Table II. When plaque
GSM was less than 25, the incidence of restenosis was
12%, in comparison with a restenosis rate of 78%
when the GSM was greater than 25 (P < .001, with
Yates correction). The relationship between plaque
GSM and PSVR is shown in Fig. 8 (r = 0.66).
The overall incidence of restenosis was 41% (13 of
31) at 24 weeks (6 months); there were no lesions that
restenosed between weeks 24 and 52 (1 year). Two
lesions with a GSM less than 25 restenosed at weeks
16 and 24. Of the lesions with a GSM greater than 25
that restenosed, 6 recurred before week 8 (55%), 3
before week 12 (28%), and 2 before week 24 (18%). A
Table I. The relationship between plaque grey-
scale median (GSM) and reduction in plaque thick-
ness on day 1 after angioplasty 
Group A Group B P value
(GSM < 25) (GSM > 25) (t test)
Plaque thickness (mm) 5.6 ± 2.2 5.2 ± 2.2 NS
(preangioplasty) (A)
Plaque thickness (mm) 2.2 ± 1.7 3.3 ± 0.9 NS
(day 1 postangioplasty) 
(B)
Absolute decrease in plaque 3.3 ± 1.8 1.8 ± 1.6 <.03
thickness (mm) (A – B)
NS, not significant.
Table II. The relationship between plaque grey-
scale median (GSM) and restenosis (peak systolic
velocity ratio [PSVR] more than 2.0) (P < .001
with Yates correction)
No stenosis Stenosis
(PSVR < 2.0) (PSVR > 2.0) Total
Plaque GSM < 25 15 2 (11.8%) 17
Plaque GSM > 25 3 11 (78.8%) 14
Total 18 13 31
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stenosis with the highest GSM (71) could not be suc-
cessfully dilated and showed evidence of restenosis on
day 1 after angioplasty. 
There was no correlation between GSM and
absolute plaque “growth.”
DISCUSSION
B-mode ultrasound imaging has been used as a
means of characterizing carotid artery bifurcation dis-
ease, and its ability to distinguish between fibrous
plaque and more complex ones containing intraplaque
hemorrhage has been described.2 Plaques were thus
classified as homogenous or heterogenous. The
homogenous plaque was defined as having a uniform
appearance of high- or medium-level echoes, which
signify a large amount of fibrous tissue. In contrast,
heterogenous plaques were defined as having discreet
bright and dark areas, because they contain lipid
deposits and hemorrhage. Other authors1 have corre-
lated plaque character with symptoms and found het-
erogenous plaques to be associated with more neuro-
logical events than homogenous ones. It has been
Fig 4. Stenosis in superficial femoral artery with a gray-scale median of 6 before angioplasty.
Anterior plaque = 4.31 mm, minimal luminal diameter = 1.14 mm, and peak systolic velocity
ratio = 2.85.
Fig 5. Stenosis shown in Fig 4 on day 1 postangioplasty. Anterior plaque = 1.32 mm (absolute
reduction in thickness = 2.99 mm), minimal luminal diameter (MLD) = 5.02 mm (absolute
increase in MLD = 3.88 mm), and peak systolic velocity ratio (PSVR) = 1.03 (percent decrease
in PSVR = 64%).
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shown that echolucent plaques (black on B-mode
imaging) are associated with a higher content of lipids
and cholesterol and occur more frequently in sympto-
matic patients; in contrast, echogenic plaques (white
on B-mode imaging) contain a larger amount of
fibrous tissue and are common in asymptomatic
patients. This is probably because echolucent plaques
with their high lipid content are more prone to rup-
ture and embolization than echogenic plaques with
their higher content of fibrous tissue and calcium.
Other publications3,4 have reported a higher incidence
of symptoms (transient ischemic attacks [TIA] and
stroke) in echolucent plaques than in echogenic
plaques. Ultrasound has also been used as a means of
studying the progression of disease and restenosis in
carotid arteries after endarterectomy.8 The assessment
of carotid plaque characteristics by means of ultra-
sound has led to a greater understanding of the natur-
al history of carotid artery disease and the identifica-
tion of high- and low-risk patients.
The main problem, however, with plaque charac-
ter assessed by means of ultrasound is that the
Fig 6. Stenosis in superficial femoral artery with a gray-scale median of 35 before angioplas-
ty. Posterior plaque = 3.96 mm, minimal luminal diameter = 2.11 mm, and peak systolic veloc-
ity ratio = 2.46.
Fig 7. Stenosis shown in Fig 6 on day 1 postangioplasty. Posterior plaque = 3.91 mm
(absolute reduction in thickness = 0.05 mm), minimal luminal diameter (MLD) = 3.69 mm
(absolute increase in MLD = 1.58 mm) and peak systolic velocity ratio (PSVR) = 1.77 (per-
cent decrease in PSVR = 28%).
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echogenicity and texture of the plaque may be
altered by instrument settings for power, dynamic
range, gray scale, etc. It is thus subjective and opera-
tor-dependent. Recent evidence5,6 has suggested that
computer-based assessment of plaque characteristics
would provide a more objective and quantitative,
operator-independent method of analysis of plaque
echolucency or echogenicity and would probably be
more accurate for the diagnosis of plaques at risk of
rupture and embolization. However, until normal-
ization of images is achieved, the reproducibility of
this method from center to center is in doubt.
Intravascular ultrasound (IVUS) is now recog-
nized as a high-resolution imaging modality and is
increasingly being used as a means of guiding the
angioplasty, atherectomy, and stenting procedure in
coronary and peripheral arteries.9–18 The experience
of imaging with IVUS has shown that it provides a
level of detail of plaque morphology that is unat-
tainable with angiography. By means of the 40 MHz
IVUS in vitro, 4 basic plaque components have been
described:11 (1) echolucent, composed of lipid
deposits; (2) soft echoes, composed of fibromuscu-
lar tissue, intimal proliferation, and varying amounts
of diffusely dispersed lipids; (3) bright echoes, com-
posed of collagen-rich fibrous tissue; and (4) bright
echoes with acoustic shadowing, composed of calci-
fied tissue. IVUS (30 to 40 MHz catheters are used
for imaging coronary arteries; 12 MHz catheters are
used for imaging peripheral arteries) has been used
as a means of deciding on the appropriate treatment
strategy. In one report, preinterventional IVUS was
performed in 301 patients with 313 target lesions, in
the coronary arteries, to determine the appropriate
treatment strategy.13 Based on the IVUS findings,
the treatment strategy that was initially formulated
on the basis of angiographic findings was changed in
40% of patients, because of newly diagnosed severe
lesions, lesion composition assessment leading to a
change in revascularization strategy, etc. Another
study14 reported similar findings, in which IVUS
findings led to a change in the interventional strate-
gy in nearly 48% of cases. Additionally, in another
study, atherosclerosis was detected in more than 90%
of angiographically normal, coronary artery refer-
ence segments by means of IVUS.15 IVUS has been
used as a means of predicting adverse outcome after
coronary angioplasty and the correlation of plaque
morphology with angiography, clinical syndrome,
and procedural results.10 It has also been used as a
means of determining the presence, magnitude,
location, and distribution of calcium within the
lesion and has been compared with coronary
angiography findings16; in this study, calcium was
detected by means of angiography in only 38% of
lesions, whereas calcium was detected by means of
IVUS in nearly 73% of cases. These findings have
been corroborated by other authors, who have
found that angiography has only a 40% sensitivity in
the detection of calcification diagnosed by means of
IVUS 17. IVUS-based studies in coronary arteries
have also shown that the location of calcium within
the lesion affects outcome, based on the revascular-
ization procedure that is chosen. For instance, rota-
tional atherectomy has been shown to be superior to
directional atherectomy for treating fibrocalcific dis-
Fig 8. Relationship between plaque grey-scale median (GSM) and peak systolic velocity ratio
(PSVR) in the postangioplasty period.
ease, especially when calcium is located at the lumi-
nal surface.18 On the other hand, if calcium is locat-
ed deep within the lesion, directional atherectomy
may be useful; the softer fibrous plaque may be
removed safely, and the calcium that is located 
deep within the lesion prevents the cutter from
entering the media, which may result in perforation.
Although IVUS is a useful periprocedural tool for
the vascular interventionist, its main drawback is that
it is invasive and, therefore, cannot be repeated at
frequent intervals.
In this study, all ultrasound images were normal-
ized with a GSM of 0 to 5 for blood and 180 to 190
for adventitia. The correlation between 2 observers
for the measurement of plaque GSM was excellent (r
= 0.93), with the 95% limits of confidence between
–4.1 and 5.9.
Balloon angioplasty works by means of the mech-
anism of plaque fracture, with extension of a dissec-
tion plane into the muscular medial wall. The rela-
tionship between plaque GSM and absolute decrease
in plaque thickness on day 1 was significant (P < .03).
The lower the plaque GSM, the more effective the
process of plaque compression with the angioplasty
balloon. This could be explained on the basis of
plaques with a GSM less than 25 being more echolu-
cent because of their higher content of cholesterol
and, therefore, more compressible than plaques with
a GSM greater than 25 because of their higher con-
tent of fibrous tissue. There was no correlation
between GSM and absolute increase in MLD or per-
cent fall in PSVR on day 1 after angioplasty. This
could be explained on the basis that, irrespective of
the nature of the plaque, angioplasty achieved its
effect, by means of compression in echolucent
plaques (GSM less than 25) or, in cases in which the
plaque is fibrous and incompressible (GSM more
than 25), by means of vessel wall dilatation.
Plaque GSM played an important role in the
long-term outcome after angioplasty; in plaques with
a GSM greater than 25, the restenosis rate was 78%,
in comparison with 12% in those with GSM less than
25 (P < .001). When GSM was greater than 30, the
restenosis rate was 100%. Indeed, in a very calcified
lesion with a GSM of 71, restenosis occurred on day
1 after the procedure. By 6 weeks, 55% of lesions
with GSM greater than 25 restenosed. However,
there was no correlation between plaque GSM and
absolute plaque “growth.” One possible explanation
is the combination of “growth” and vessel wall recoil
in plaques with GSM greater than 25 (because angio-
plasty worked in these cases by vessel wall dilatation)
led to lumen loss and restenosis. 
None of the patients in our study had stenting of
the arteries after angioplasty. The Dutch Iliac Stent
Trial Group19 recently published the results of a
study comparing primary stent placement vs prima-
ry angioplasty followed by selective stent placement
for patients with iliac artery occlusive disease.
Selective stenting was performed if angioplasty alone
revealed a residual mean pressure gradient of more
than 10 mm at the treated site. This study found no
differences in treatment strategies both at short-
term and long-term follow-up. The investigators
concluded that because selective stent placement is
less expensive, it is a better option than direct stent
placement for the treatment of iliac occlusive dis-
ease. However, this finding cannot be applied to our
experience, because of the small numbers in our
study and also because the diagnosis of restenosis
was based on an increase in the Duplex criterion of
PSVR of more than 2 at the site of angioplasty and
not on recurrence of patient symptoms. 
An important finding in this study was a high
rate of restenosis after balloon angioplasty alone in
lesions with a high GSM. Therefore, the selection of
lesions for angioplasty, based on plaque GSM, could
have better therapeutic results. In the case of a calci-
fied lesion with a very high GSM of 71, it could not
be dilated adequately by means of balloon angio-
plasty alone and showed restenosis (PSVR more
than 2) on day 1 after angioplasty. The assessment of
plaque GSM before the procedure will help the
interventionist plan the appropriate treatment strat-
egy. For lesions with a low GSM, balloon angioplas-
ty alone will suffice. However, for fibrocalcific
lesions with a high GSM, adjunctive procedures may
be needed. Although it is outside the scope of this
paper to discuss the best treatment strategies, angio-
plasty followed by stenting or atherectomy and
stenting would seem logical choices. 
Additionally, the identification of a high-risk
group in patients undergoing angioplasty will be
beneficial for future studies in which pharmacologi-
cal agents aimed at reducing restenosis are tested;
because the prevalence of restenosis will be high, the
numbers needed to demonstrate the expected differ-
ence may be small.
Future studies with larger series of lesions
assessed on the basis of ultrasound are needed to
lead to a better understanding of the mechanisms
involved. The cutoff point of a GSM of 25 should be
assessed prospectively in further studies. Also, future
studies should correlate ultrasonic plaque character-
istics with histological specimens in lesions that have
restenosed; this could provide insight into the histo-
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logic elements that contribute to restenosis and their
associated ultrasonic characteristics.
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Dr R. Eugene Zierler (Seattle, Wash). Although the
degree of stenosis produced by an atherosclerotic plaque
has traditionally served as both the principal indicator for
intervention and the means for assessing the clinical out-
come, there are other features of plaques that may be
important. Examples of such features include ulceration,
hemorrhage, and calcification. However, attempts to iden-
tify plaque histology based on B-mode ultrasound have
met with variable success. 
The study of atherosclerotic lesions by means of ultra-
sound is difficult, because of the many technical issues that
are involved in producing the images and the lack of any
standardized criteria for their interpretation. Thus, plaque
characterization by means of ultrasound has been too sub-
jective and qualitative to be useful in the clinical setting. 
In fact, our group in Seattle has shifted from ultrasound
to other approaches, such as MR imaging, for plaque char-
acterization. However, in an effort to obtain a more objec-
tive and quantitative assessment of plaque features, the group
at St. Mary’s Hospital has developed a computer-assisted
ultrasound technique that relies on the gray-scale median as
a measure of overall plaque echogenicity. This technique was
first described in 1995 and until now has been applied pri-
marily to the characterization of carotid artery plaques. 
This paper by Ramaswami and colleagues extends the
application of this computer-assisted technique from the
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carotid to the peripheral arteries. They found that rela-
tively echolucent lesions with a gray-scale median less than
25 had a significant reduction in plaque thickness imme-
diately after angioplasty, compared with more echogenic
lesions. Similarly, the restenosis rate was only 12% when
the gray-scale median was less than 25, in contrast to 79%
for lesions with a gray-scale median greater than 25. When
the gray-scale median was greater than 30, the restenosis
rate was 100%. 
The results of this study suggest that the outcome of
balloon angioplasty can be predicted based on plaque
echogenicity as measured by means of the gray-scale medi-
an. If this is true, then such a technique could be used to
select patients for intervention and to identify those
patients who might benefit from adjunctive mechanical or
pharmacologic therapies. However, as the authors point
out, this approach must be validated prospectively. 
I would like to pose the following questions to Dr.
Ramaswami and his coauthors.
First, because this study included 31 stenoses in 17
patients, it is obvious that many of the patients had more
than 1 lesion treated. In this situation, multiple lesions in a
single patient are subject to the same general risk factors for
restenosis. Therefore, the risk of restenosis in these lesions
is not truly independent. There are statistical methods for
dealing with these circumstances, but it is not clear that such
methods were used in your analysis. Do you have any data
on the role of patient factors such as sex, smoking, or dia-
betes on the outcome of balloon angioplasty in your study? 
Second, the results of balloon angioplasty tend to be
better in the iliac than the more distal arterial segments.
Was there any difference in gray-scale median or other
predictive parameters based on location of the lesion (for
example, the common or external iliac, compared with the
superficial femoral arteries)? 
Finally, severe plaque calcification is quite common in
peripheral atherosclerotic lesions and produces acoustic
shadowing with loss of gray-scale information from the
deeper tissues. How is this situation dealt with in deter-
mining the gray-scale median by the computer-assisted
technique? 
I compliment the authors on this interesting study and
appreciate the opportunity to discuss it. 
Dr Ganesh Ramaswami. Thank you, Dr. Zierler. In this
group, there were 31 stenoses in 17 patients. We looked at
the risk factors of sex, smoking, diabetes, hypercholesterine-
mia, and hypertension and found no difference between the
lesions that restenosed and the ones that did not. 
I would like to reiterate here that the restenosis criterion
that we used for the study was an increase in the peak systolic
velocity ratio to more than 2.0 at the site of angioplasty, and
not the recurrence of symptoms associated with a fall in ankle
brachial indices during the postangioplasty period.
In answer to your second question, the gray-scale
median of the iliac lesions averaged 29, and the gray-scale
median of the femoropopliteal lesions averaged 32. There
was no significant difference in the gray-scale median
between these lesions. 
About your third question on the role of plaque calci-
fication and how that would interfere with the measure-
ment of the gray-scale median, if plaque calcification pro-
duced acoustic shadowing, measurements of the plaque
gray-scale median cannot be done. On the other hand, if
there was calcification that did not produce significant
shadowing, the gray-scale median could still be measured. 
I would like to add that the presence of calcium in the
plaque would increase the gray-scale median of the lesion.
Dr Alexander W. Clowes (Seattle, Wash). One of the
things that I noted in your presentation was that you are
very careful not to describe the mechanism of stenosis or
restenosis. We now know by means of intravascular ultra-
sound that angioplasty restenosis is largely caused by
pathological remodeling, a form of shrinkage, and not by
intimal hyperplasia, whereas in the stent it’s caused by inti-
mal hyperplasia. Do you have any information about the
mechanism of restenosis? And do you think that the obser-
vations you have made will predict restenosis inside a
stented vessel and inside an angioplastied vessel? 
Dr Ramaswami. Measuring plaque thickness in the
stented vessel may not be that easy, because the stent
metal may cause echo reverberations in the proximal wall.
We did not have any patients who were stented in this
group. They all underwent balloon angioplasty.
I do agree that there are other mechanisms involved in
the restenotic process. Because this study was with trans-
cutaneous ultrasound, we measured plaque gray-scale
median and correlated this with plaque thickness, minimal
luminal diameter, and peak systolic velocity ratio changes
in the postangioplasty period. All that we can say is there
was a higher restenosis rate in the group with the higher
gray-scale median. This could possibly be caused by
fibrous plaques being incompressible and the mechanism
of angioplasty in these lesions, purely by stretching the
vessel wall, so the component of plaque growth followed
by vessel wall recoil in this group led to a higher rate of
restenosis. 
Dr Samuel S. Ahn (Los Angeles, Calif). I congratulate
the authors for bringing to our attention a potentially useful
way to better select patients for balloon angioplasty, but I
have 2 issues to raise. First, how did you come up with your
criterion for restenosis? You used a peak systolic ratio greater
than 2.0 as a restenosis rate. In my own practice, I’m not
sure exactly what criteria we should use for saying whether
that restenosis is significant. Furthermore, how does that
peak velocity ratio of 2.0 correlate to ankle-arm index, exer-
cise ankle-arm index, the patient’s symptoms, etc.? 
The second issue regards your comments about possibly
stenting those patients with the higher density echogenicity.
Stents do not necessarily prevent restenosis. There is no
good data that supports using stents in this situation.
Dr Ramaswami. Thank you, Dr. Ahn. In answer to
your first question about the peak systolic velocity ratio of
2.0, we used that because it’s a well-established criterion
signifying more than 50% reduction in diameter. All these
lesions had the peak systolic velocity ratio (PSVR) mea-
sured before the procedure, and the PSVR was less than
JOURNAL OF VASCULAR SURGERY
Volume 29, Number 1 Ramaswami et al 121
2.0 immediately after angioplasty. We took an increase in
the PSVR to more than 2.0 to indicate restenosis, because
this would mean that the lesion had recurred. But this was
not symptomatic restenosis. In a proportion of the
patients, the peak systolic velocity ratio increased to more
than 2.0, despite patients being asymptomatic and also the
ankle brachial index showing no fall. 
Regarding your second question about stenting,
because this group underwent balloon angioplasty with
restenosis that we could predict on the basis of the gray-
scale median, we proposed that stenting could be a better
procedure to keep these vessels open, because angioplasty
achieved its effect in these lesions with a high gray-scale
median purely by stretching the vessel wall, rather than
compressing the plaque. I do agree with you that stents do
not necessarily prevent restenosis. Perhaps we should con-
sider other procedures, such as atherectomy, in fibrocalcif-
ic lesions with a high gray-scale median as an adjunct pro-
cedure to balloons and stenting.
Dr Ross Lyon (New York, NY). I greatly enjoyed your
paper. 
My question relates to other characteristics, morpho-
logic characteristics, of plaque. There certainly may be
other characteristics that are important in determining the
effectiveness of balloon angioplasty. Did you look at
plaque circumference of the arterial wall? Also, did you
look at plaque length? And if you did, what did you find? 
Dr Ramaswami. Thank you. Transverse section imag-
ing of these arteries is suboptimal, so we had to go purely
by the longitudinal images. We do realize that with longi-
tudinal measurements we still miss the plaques on the side
of the artery, but we made sure that we were at the same
site in every instance, we got the maximum thickness of
the anterior and the posterior component of the plaque,
and this was used to calculate the gray-scale median, the
changes in plaque thickness, minimal luminal diameter,
and peak systolic velocity ratio during follow-up. We did
not calculate plaque circumference. Also, these lesions
were less than 5 cm long.
Dr Sergio X. Salles-Cunha (Toledo, Ohio). I am curi-
ous about the complexity of the plaque. Was there any
additional information in the variance, standard deviation,
or the histogram of the echo measurements? 
Dr Ramaswami. We did not take the mean, we took
the median, because the histogram was skewed. And so,
the gray-scale median of the pixels of the histogram was
used as a measure of plaque echodensity. We did not mea-
sure the variance of the standard deviation. 
Dr Salles-Cunha. So, did you study that histogram?
Was there any additional information, if the histogram was
wide or narrow? 
Dr Ramaswami. Yes, if the histogram was wide, it
meant that the plaque had both echolucent and echogenic
areas. That meant the spread of the histogram was broad-
er. In comparison, if you had a purely echolucent plaque,
then the spread of the histogram was narrower. 
Dr Christopher K. Zarins (Stanford, Calif). I wonder
if you could explain to me the concept of plaque compres-
sion. Is it possible to compress a solid, a liquid, or both? 
Dr Ramaswami. Well, plaque volume remains con-
stant. Looking at the images that we had of echolucent
plaques immediately after the angioplasty, we saw that the
angioplasty balloon flattens out the plaque and spreads it
axially across the length of the vessel. So, there was a sig-
nificant decrease in the plaque thickness that we could
measure by means of ultrasound, and this we referred to
as plaque compression. 
Dr Zarins. But you’re not actually compressing the
plaque, you’re redistributing it; you’re flattening it, not
actually compressing it. 
Dr Ramaswami. Yes, in comparison with the echogenic
fibrous plaques that are incompressible. So, there is no
decrease in the plaque thickness, but angioplasty still
achieves its effect by stretching the vessel wall. 
